Indian scientists have built one of the world’s largest Covid-19 bio-banks storing over 5,000 samples from SARS-CoV2 patients to support understanding of the disease and help domestic and global research on wide-ranging aspects of Covid.
The samples have been stored under the highest biosafety levels at the Translational Health Science and Technology Institute (THSTI), Faridabad, an autonomous institution with leading capacities in clinical research and product development.
Based on the massive bio-repository of Covid samples it has, the Department of Biotechnology Institute, THSTI, has also launched a major longitudinal study to understand the immune and antibody response among patients, the causes behind disease severity, the scale of re-infection and “long Covid” conditions among those infected.
Click here to read more.